Gene · 3039
NIH grants1,435
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,435
Download this page as JSON| Grant | Title | HBA1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA157644 | Central tolerance mechanisms in B-cell malignancies | 1 | 2025 |
| R01CA241410 | Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels | 1 | 2025 |
| R01CA255240 | In situ radioimmunotherapy to maximize the engagement of conventional type 1 dendritic cells against non-T cell-inflamed tumors | 1 | 2025 |
| R01DA008863 | Regulation Of Opioid Receptor Signaling by Endogenous Peptides | 1 | 2025 |
| R01DC004428 | Characterization and treatment of the scarred vocal fold | 1 | 2025 |
| R01DE018304 | ART Modulation of Viral Pathogenesis | 1 | 2025 |
| R01DK078244 | Molecular Basis of Pathogenicity of IgA1-containing Immune Complexes | 1 | 2025 |
| R01DK107716 | Regulation and manipulation of the telomerase RNA component in hematopoiesis | 1 | 2025 |
| R01DK111430 | Molecular Analysis of Transcriptional Enhancers in Hematopoiesis | 1 | 2025 |
| R01DK128390 | Selenium metabolism in cold-induced adaptive thermogenesis | 1 | 2025 |
| R01DK133475 | Development and validation of novel mouse models and expression vectors for characterizing severe alpha-thalassemia pathophysiology and evaluating gene therapy approaches. | 1 | 2025 |
| R01ES032638 | The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes. | 1 | 2025 |
| R01EY018213 | Defining Barriers to Gene Therapy | 1 | 2025 |
| R01EY024698 | Gene Editing and Silencing in Phototransduction | 1 | 2025 |
| R01GM058460 | Chromatin Domain Structure and Function | 1 | 2025 |
| R01GM102155 | Lipid droplets as protein sequestration sites | 1 | 2025 |
| R01GM114362 | Computational methods for detecting patterns of complex genomic variation | 1 | 2025 |
| R01GM126553 | New directions in single cell genomics method development | 1 | 2025 |
| R01HD094937 | Modeling Normal and Abnormal Trophoblasts | 1 | 2025 |
| R01HG002385 | Long-read sequence and assembly of segmental duplications | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/grants?page=8